Malinckrodt

MNK NYSE
9.87
-3.16
-24.25%
Closed 19:52 05/21 EDT
Open
9.14
Prev Close
13.03
High
9.94
Low
8.45
Volume
17.10M
Avg Vol (3M)
2.51M
52 Week High
36.65
52 Week Low
8.45
% Turnover
20.40%
Market Cap
827.24M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Malinckrodt MNK stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.
MORE >

Recently

Name
Price
%Change